HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia

Medicine & Life Sciences

• 2-(2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)biphenyl-3-yloxy)acetic acid 100%
• HDL Lipoproteins 51%
• Nanoparticles 43%
• Leukemia 40%
• Acute Myeloid Leukemia 29%
• Methyltransferases 9%
• Myeloid Cells 9%
• Therapeutics 8%
• DNA 7%
• Fatty Acid-Binding Proteins 5%
• Oligonucleotides 4%
• Gold 4%
• DNA Methylation 4%
• Cell Differentiation 3%
• Disease Progression 3%
• Down-Regulation 3%
• Growth 2%
• Pharmaceutical Preparations 1%
• Neoplasms 1%

Engineering & Materials Science

• Lipoproteins 83%
• Nanoparticles 48%
• DNA 13%
• Molecules 8%
• DNA Methylation 7%
• Carrier Proteins 7%
• Gold nanoparticles 7%
• Oligonucleotides 6%
• Zeta potential 6%
• Fatty acids 5%
• Tumors 4%
• Transmission electron microscopy 4%
• Restoration 4%
• Engineers 3%

Chemical Compounds

• Nanoparticle 24%
• High-Density Lipoprotein 15%
• Oligonucleotide 10%
• Gold Nanoparticle 10%
• Shape 7%
• Drug 6%
• Protein 5%